In trading on Tuesday, shares of Arcus Biosciences Inc (Symbol: RCUS) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $13.08 per share. By ...

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual ...

Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...

Houston-based Moleculin Biotech, Inc., currently trading at $0.80 and showing a market capitalization of $2.4 million, has entered into an agreement with an investor to modify certain terms of ...

PMGC Holdings Inc. (NASDAQ:ELAB), a pharmaceutical preparations company, announced on Monday that it has successfully completed transactions under a warrant inducement agreement, resulting in gross ...

EST Aptose Biosciences (APTO) files to sell 12.03M shares of common stock for holdersMaximize Your Portfolio with Data Driven ...

American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...

Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

EVENTS DURING THE FOURTH QUARTEREuropean Patent Office granted Active Biotech's patent application for eye drop formulation of laquinimod (October 23)Active Biotech's clinical trial of tasquinimod in ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

My Beginnings," Bill Gates explained the different approaches he took when applying to Yale, Harvard, and Princeton.